Silencing circular RNA circZNF609 restrains growth, migration and invasion by up-regulating microRNA-186-5p in prostate cancer

References

• Noguchi, M, Koga, N, Igawa, T, et al. Clinical development of immunotherapy for prostate cancer. Int J Urol. 2017;24:675–680.
   PubMed Web of Science ®Google Scholar
• Ren SC, Chen R, Sun YH. Prostate cancer research in China. Asian J Androl. 2013;15:350–353.
   PubMed Web of Science ®Google Scholar
• Grozescu T, Popa F. Prostate cancer between prognosis and adequate/proper therapy. J Med. Life. 2017;10:5–12.
   PubMedGoogle Scholar
• Castillejos-Molina RA, Gabilondo-Navarro FB. Prostate cancer. Salud Publica Mex. 2016;58:279–284.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski MK, Recker F, Piironen T, et al. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL. Urology. 1998;52:360–365.
   PubMed Web of Science ®Google Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12:381–388.
   PubMed Web of Science ®Google Scholar
• Hamam R, Hamam D, Alsaleh KA, et al. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. Cell death Dis. 2017;8:e3045.
   PubMed Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16:94.
   PubMed Web of Science ®Google Scholar
• Legnini I, Di Timoteo G, Rossi F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol cell. 2017;6;66:22–37.e9.
   Web of Science ®Google Scholar
• Zhu L, Liu Y, Yang Y, et al. CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p. Eur Rev Med Pharmacol Sci. 2019;23:2817–2826.
   PubMed Web of Science ®Google Scholar
• Cai Y, Yu X, Hu S, et al. A brief review on the mechanisms of miRNA regulation. GPB. 2009;7:147–154.
   Google Scholar
• Calin GA, Liu CG, Sevignani C, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA. 2004;101:11755–11760.
   PubMed Web of Science ®Google Scholar
• Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol Mech Dis. 2014;9:287–314.
   PubMed Web of Science ®Google Scholar
• Acunzo M, Romano G, Wernicke D, et al. MicroRNA and cancer–a brief overview. Adv Biol Regul. 2015;57:1–9.
   PubMedGoogle Scholar
• Li J, Xia L, Zhou Z, et al. MiR-186-5p upregulation inhibits proliferation, metastasis and epithelial-to-mesenchymal transition of colorectal cancer cell by targeting ZEB1. Arch Biochem Biophys. 2018;640:53–60.
   PubMed Web of Science ®Google Scholar
• Jiao D, Wu M, Ji L, et al. MicroRNA-186 suppresses cell proliferation and metastasis through targeting sentrin-specific protease 1 in renal cell carcinoma. Oncol Res. 2018;26:249–259.
   PubMed Web of Science ®Google Scholar
• Jones DZ, Schmidt ML, Suman S, et al. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. BMC Cancer. 2018;18:421.
   PubMed Web of Science ®Google Scholar
• Bezrukov EA, Rapoport LM, Shpot EV, et al. Prostate cancer of high oncological risk. Current trends in diagnosis and surgical treatment. Urologiia (Moscow, Russia: 1999). 2017;4:129–134.
   PubMedGoogle Scholar
• Wang S, Xue X, Wang R, et al. CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6K1 via sponging miR-145-5p. CMAR.. 2018;10:3881–3890.
   Web of Science ®Google Scholar
• Rong D, Sun H, Li Z, et al. An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017;8:73271–73281.
   PubMedGoogle Scholar
• Dai Y, Li D, Chen X, et al. Circular RNA myosin light chain kinase (MYLK) promotes prostate cancer progression through modulating Mir-29a expression. Med Sci Monit. 2018;24:3462–3471.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhang J, Song C. CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. J Cell Physiol. 2019;234:10646–10654.
   PubMed Web of Science ®Google Scholar
• Tian J, Shen R, Yan Y, et al. miR-186 promotes tumor growth in cutaneous squamous cell carcinoma by inhibiting apoptotic protease activating factor-1. Exp Ther Med. 2018;16:4010–4018.
   PubMed Web of Science ®Google Scholar
• Hua X, Xiao Y, Pan W, et al. miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3. Am J Cancer Res. 2016;6:1650–1660.
   PubMed Web of Science ®Google Scholar
• Zhu P, Wang Y, Wu J, et al. LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells. Nat Commun. 2016;7:13608.
   PubMed Web of Science ®Google Scholar
• Sugiyama M, Takahashi H, Hosono K, et al. Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol. 2009;34:339–344.
   PubMed Web of Science ®Google Scholar
• Sheng X, Li WB, Wang DL, et al. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells. Mol Med Rep. 2015;12:4867–4876.
   PubMed Web of Science ®Google Scholar
• Chen RJ, Hung CM, Chen YL, et al. Monascuspiloin induces apoptosis and autophagic cell death in human prostate cancer cells via the Akt and AMPK signaling pathways. J Agric Food Chem. 2012;60:7185–7193.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhao X, Zhang J, et al. Circular RNA hsa_circ_0023404 exerts an oncogenic role in cervical cancer through regulating miR-136/TFCP2/YAP pathway. Biochem Biophys Res Commun. 2018;501:428–433.
   PubMed Web of Science ®Google Scholar
• Zhou GK, Zhang GY, Yuan ZN, et al. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma. Eur Rev Med Pharm Sci. 2018;22:8772–8780.
   PubMed Web of Science ®Google Scholar
• Chen MB, Wei MX, Han JY, et al. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer. Cell Signal. 2014;26:102–109.
   PubMed Web of Science ®Google Scholar